South Korean MedTech firm AdipoLABs opens Asia-Pacific Regional Office in Malaysia to drive healthcare innovation

MALAYSIA—AdipoLABs Co., Ltd. and Red & Blue Co., Ltd. from South Korea, alongside their Malaysian subsidiary AdipoLABs Healthcare (M) Sdn Bhd, have inaugurated their new regional office for Asia-Pacific in Malaysia.

This strategic move strengthens the company’s position in non-invasive healthcare while establishing a comprehensive MedTech ecosystem across Malaysia and ASEAN.

The research and development-focused medical company aims to facilitate knowledge transfer, promote R&D collaboration, deliver industry-standard training, and enhance preventive healthcare capabilities throughout the region.

To mark this expansion, the company signed two Memoranda of Understanding with the University of Cyberjaya (UoC) to establish a formal partnership in healthcare innovation, clinical research, and talent development.

Mr. Han Sung-ho, CEO of AdipoLABs Co., Ltd., emphasized that combining their hyperthermia technology with local expertise and academic excellence will accelerate the adoption of advanced healthcare solutions and improve patient outcomes globally.

He views this collaboration as a model for international healthcare partnerships.

The first MoU establishes a comprehensive internship programme with UoC’s Faculty of Health, offering six-month placements with potential employment opportunities.

Physiotherapy students will gain practical experience with AdipoLABs’ Pain Bot device, developing skills in pain detection and treatment, while biomedical engineering students will support technical operations, including after-sales service and device maintenance.

AdipoLABs will implement a strategic client engagement initiative where interns work at client facilities to demonstrate device effectiveness and provide on-site support.

This approach showcases the interns’ capabilities, encourages permanent employment opportunities, and ensures optimal technology utilization.

The partnership also encompasses clinical research, with UoC professors and students conducting studies on various AdipoLABs medical devices to generate evidence-based insights for publication in reputable journals.

Dr. Isaac R. Joseph, Director of AdipoLABs Healthcare (M) Sdn Bhd, expressed enthusiasm about collaborating with UoC to develop local talent and advance Malaysian healthcare innovation.

He highlighted that the partnership provides students with hands-on experience with technologies such as Pain Bot while expanding clinical research to enhance pain management solutions for patients across Malaysia and ASEAN.

The second MoU focuses on knowledge transfer and medical device donation.

Under this agreement, AdipoLABs Malaysia will donate a Pain Bot unit to UoC, giving students access to advanced pain detection and treatment technology while enhancing their expertise in innovative musculoskeletal pain management methods.

AdipoLABs operates as a Ministry of Health (MOH)-registered medical device establishment under the Medical Device Authority (MDA), providing regulatory credibility and demonstrating commitment to quality and innovation.

Professor Dr. David Whitford, Vice-Chancellor of the University of Cyberjaya, described the partnership as a direct investment in future healthcare professionals, noting that advanced rehabilitative technologies give students access to international-standard tools and real-world innovation.

Professor Dr. Yoo Seung-mo from South Korea, the inventor of Pain Bot, will serve as an adjunct professor at UoC, providing on-site training and ongoing remote mentorship to ensure students receive expert guidance on using Pain Bot technology and applying advanced pain-detection techniques.